Analyze Diet

Adverse effects following intravenous fluid therapy in the horse using non-commercial fluids: preliminary findings.

Abstract: Non-commercial, endotoxin positive, intravenous fluids as well as a commercially available intravenous fluid were given to clinically normal horses. Endotoxin-positive fluids caused clinical signs attributable to endotoxaemia. Leukopenia, preceded by a fluctuating white cell count, was observed in horses showing clinical signs. The commercial intravenous fluid had no effect on the white cell count or on the clinical state. Precautions to be taken and recommendations are made with regard to the monitoring of horses in which one might be forced to use non-commercial intravenous fluids.
Publication Date: 1986-06-01 PubMed ID: 3795221
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the adverse effects in horses following the administration of non-commercial, endotoxin-positive intravenous fluids, compared to a commercial intravenous fluid. Results showed clinical signs attributable to endotoxaemia in horses given endotoxin-positive fluids, suggesting careful monitoring and precautions when using non-commercial intravenous fluids.

Non-Commercial Intravenous Fluids and Endotoxaemia in Horses

  • The researchers studied the effects of both non-commercial intravenous fluids positive for endotoxin (a toxin kept within the bacteria and released upon the bacteria’s destruction), and a commercially available intravenous fluid on horses.
  • The horses given the endotoxin-positive fluids showed clinical signs attributable to endotoxaemia, a harmful condition caused by a high concentration of endotoxins in the blood.
  • Leukopenia, a decrease in the number of white blood cells, was observed in horses showing these clinical signs. This condition’s onset was indicated by an unpredictable fluctuation in the white cell count.

Effects of Commercial Intravenous Fluid

  • The commercially available intravenous fluid used in the study did not induce the same kind of adverse effects.
  • There were no changes in the white cell count or clinical state of the horses given the commercial intravenous fluid. This suggests that the commercial fluid is safer for use in horses.

Precautions and Recommendations

  • The study affirms the need for caution when non-commercial intravenous fluids are used, especially if they are endotoxin-positive.
  • If one must use non-commercial intravenous fluids in horses, close monitoring of the horse’s health is recommended. Tracking changes in the white cell count is a critical part of this monitoring, as fluctuations could indicate the onset of adverse reactions like leukopenia.
  • Overall, the study promotes the usage of commercially available intravenous fluids over non-commercial ones, provided the latter are absolutely necessary.

Cite This Article

APA
Denkhaus M, Van Amstel S. (1986). Adverse effects following intravenous fluid therapy in the horse using non-commercial fluids: preliminary findings. J S Afr Vet Assoc, 57(2), 105-107.

Publication

ISSN: 1019-9128
NlmUniqueID: 7503122
Country: South Africa
Language: English
Volume: 57
Issue: 2
Pages: 105-107

Researcher Affiliations

Denkhaus, M
    Van Amstel, S

      MeSH Terms

      • Animals
      • Electrolytes / standards
      • Endotoxins / adverse effects
      • Fluid Therapy / adverse effects
      • Fluid Therapy / veterinary
      • Horses / physiology
      • Infusions, Intravenous / veterinary
      • Leukocyte Count

      Citations

      This article has been cited 2 times.
      1. Crabtree NE, Epstein KL. Current Concepts in Fluid Therapy in Horses. Front Vet Sci 2021;8:648774.
        doi: 10.3389/fvets.2021.648774pubmed: 33855057google scholar: lookup
      2. Magnusson CB, Poulsen KP, Budde JA, Hartmann FA, Aulik NA, Raabis SM, Moreira ASD, Darien BJ, Peek SF. Quality Control of Compounded Crystalloid Fluids for Intravenous Delivery to Horses. J Vet Intern Med 2018 Jan;32(1):469-473.
        doi: 10.1111/jvim.14864pubmed: 29114956google scholar: lookup